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ABSTRACT
Discrete choice experiments (DCE) and conjoint analysis (CA) are increasingly used to address health policy 
issues. This is because the DCE and CA approaches have theoretical foundations in the characteristics 
theory of demand, which assumes goods, services, or healthcare provision, can be valued in terms of their 
characteristics (or attributes). As a result, such analysis is grounded in economic theory, lending theoretical 
validity to this approach.
With DCEs, respondents are also assumed to act in a utility-maximising manner and make choices contingent 
upon the levels of attributes in DCE scenarios. Therefore, choice data can be analysed using econometric 
methods compatible with random utility theory (RUT) or random regret minimisation (RRM) theory. This 
means they have additional foundations in economic theory. In contrast, analyses described as CAs are 
sometimes compatible with RUT or RRM, but by definition they do not have to be. 
In this paper we review the CA/DCE evidence relating to nephrology. The CA/DCE approach is then 
compared with other approaches used to provide either quality of life information or preference 
information relating to nephrology. We conclude by providing an assessment of the value of undertaking 
CA  or  DCE  analysis  in  nephrology,  comparing  the  application  of  CA/DCEs  in  nephrology  with  other                                                                         
methodological approaches.
Keywords:  Renal, nephrology, conjoint analysis, discrete choice experiments, literature review,             
transplantation, dialysis.
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BACKGROUND
Table 1 provides an example of attributes and levels 
for conjoint analysis/discrete choice experiments 
(CA/DCE),1,2 whilst figure 1 is a DCE question used for 
it. DCE and CA methods involve the characteristics 
theory of demand.3 By definition, DCEs must conform 
to either random utility theory (RUT) or random 
regret minimisation (RRM).4,5  However, sometimes 
CAs do not conform to RUT/RRM, so such analysis 
may not be rigorously grounded in economic 
theory. This is because although CAs do conform to 
Lancaster’s characteristic’s theory of demand, they 
may not conform to RUT or RRM theory, whereas 
DCEs do.
If attributes are significant, data analysis confers 
information relating to how average the respondent’s 
utility, or willingness to pay (WTP), is affected by 
changes in the levels of attributes, and the impact 
of different attribute levels upon choice can then be 
quantified. This information can help decide which NEPHROLOGY  •  July 2013    EMJ EUROPEAN MEDICAL JOURNAL 53
patient groups ought to be prioritised for kidney 
transplants, when dialysis should be provided, or 
which modality is used.
METHODS – LITERATURE SEARCH
We conducted PubMed literature searches using 
keywords ‘discrete choice experiment’ or ‘conjoint 
analysis’ and ‘renal transplant’ or ‘renal dialysis’, 
reviewing DCE/CA papers identified. We also 
included a DCE conference abstract.6
RESULTS 
The literature searches revealed four papers, for three 
studies involving DCE/CA for renal transplantation.1,2,7,8 
Other DCE/CA studies (five papers, for four studies) 
relate to dialysis.8-12 Preliminary findings (conference 
abstract) about a dialysis DCE,6 are also considered. 
A summary of some key features of these studies is 
provided in Table 2.
Renal Transplant DCE/CA Analyses
A Canadian renal transplant DCE8 of 150 healthcare 
professionals, 169 patients, and 32 caregivers 
involved decisions about end-of-life care in chronic 
kidney disease. The DCE had six attributes, two 
related to transplantation: ‘how should live kidneys 
for transplantation be obtained?’ (levels of first come 
first served, or best match); and ‘how should live 
kidneys for transplantation be obtained? (levels of 
family member, paired kidney exchange, anonymous 
donor, or buy a kidney). Other attributes included 
‘who provides comprehensive day-to-day care; 
when should end-of-life care discussions be started; 
how much information on prognosis end-of-life care 
issues should be provided, and how should decisions 
to stop dialysis be made?’. Findings suggested 
patients/healthcare professionals preferred detailed 
prognostic information, and shared to individual care 
planning, and co-ordinated care. For transplants they 
preferred ‘best match’ to ‘first-come first served’ 
allocation criteria, whilst donor donation by family 
members/friends was most preferred followed by an 
unknown donor, paired kidney exchange, and buying 
a kidney. 
A USA study7 involved a CA of 175 patients. It looked 
at preferences for accepting a kidney from donors at 
increased risk of blood-borne viral infection (DIRVI). 
It considered the influence of HIV infection risk, 
donor age, and transplant waiting time (years). Key 
findings were that 24% of respondents would not 
accept a DIRVI kidney at all, 58.9% would under some 
circumstances, and 17.7% always accepted DIRVI 
kidneys. Patients would be more likely to accept 
a DIRVI kidney when waiting times were longer, 
donors were younger, and when HIV infection risk 
was lower. Dialysed patients and older patients were 
more likely to accept a DIRVI kidney. This is a CA, not 
a DCE, and so results may not be compatible with 
RUT/RRM, and may not be as rigorously grounded in 
microeconomic theory.
A UK renal transplant DCE study,1,2 assessed 
preferences of 908 patients, 113 healthcare 
professionals, 48 live donors/relatives of deceased 
donors, and 41 carers. Attributes and levels are 
shown in Table 1.  
Patients highly valued transplant waiting time and 
quality of tissue match, prioritising those with child 
or adult dependents and transplanting younger 
adults. Those with moderate diseases affecting life 
expectancy were prioritised over those with severe 
diseases, but those with moderate diseases affecting 
length of life were not prioritised over those without 
other disease(s). Patients prioritised those with 
moderate rather than no disease, and moderate 
rather than severe disease affecting quality of life. 
Ethnic minority patients did not prioritise recipients 
with close donor-recipient tissue matches, as this 
disadvantages them.
Healthcare professionals valued allocation based 
on tissue match less than patients, but valued 
prioritising those with dependents more. They also 
valued prioritising those with no diseases rather 
than moderate diseases affecting life expectancy, 
whereas patients did not. Healthcare professionals 
also valued prioritising those with severe rather 
than moderate diseases affecting quality of life 
more than patients. Carers did not value prioritising 
those with better tissue matches or those with 
dependents. However, they valued prioritising those 
with moderate, not severe, diseases affecting life 
expectancy more than patients. The live donors/
relatives of deceased donors group did not value 
prioritising kidney transplants on the basis of tissue 
match. However, they valued transplants to those 
with dependents, younger recipients, and to those 
with moderate rather than severe diseases affecting 
life expectancy, more than patients.
Results are broadly in line with current UK renal 
transplant policy, but another criterion (whether 
recipients had adult or child dependents) was also 
valued, and differences in ethnic minority patient 
preferences were highlighted. NEPHROLOGY  •  July 2013    EMJ EUROPEAN MEDICAL JOURNAL 54
Attribute Description of attribute in questionnaire 
preamble
Levels for the attribute 
that appear at different 
levels across questionnaire 
questions
A) Amount of 
time a person 
has waited for a 
kidney transplant
Timescales for people receiving a transplant after 
being placed on a waiting list are likely to differ. 
The waiting time could be (see next column)
1) 1 month.
2) 2 years.
3) 10 years.
B) Tissue type 
matching – 
and likelihood 
of transplant 
success
This affects the likelihood of a transplant proving 
to be successful. Below are the up-to-date 
figures from UK Transplant for the survival of all 
transplants in the UK. There are 6 main tissue 
types used in matching. A perfect tissue type 
match is all 6 types matching; favourable is 4-5 
out of 6 matching, non-favourable is less than 
4 matching. If a transplant fails the patient will 
return to renal dialysis (see next column)
1) Non-favourable tissue 
match (86% average survival 
rate of the kidney 1 year after 
the transplant).
2) Favourable tissue match 
(89% average survival rate 
of the kidney 1 year after the 
transplant).
3) Perfect tissue type match 
(90% average survival rate 
of the kidney 1 year after the 
transplant).
C) How many 
dependents 
(either children 
or adults) 
recipients have
Some respondents might consider that those 
who have dependent children, or others who 
are dependent either because of their age or 
a physical or mental handicap, ought to be 
prioritised for kidney transplant. So we assume 
that respondents might have (see next column)
1) No dependents.
2) 1 dependent.
3) 4 dependents.
D) Recipient age The recipient could be aged either (see next 
column)
1) 20 years.
2) 45 years.
3) 65 years.
E) Diseases 
affecting life 
expectancy
As well as having kidney failure, someone 
may have other conditions prior to kidney 
transplantation which affect their life expectancy. 
Some of the conditions which reduce life 
expectancy may occur in young people, and some 
older people may be entirely healthy apart from 
kidney disease. We assume these could be either 
(see next column)
1) None.
2) Moderate diseases 
(uncontrolled hypertension or 
obesity).
3) Severe diseases (heart 
attack, stroke, or diabetes 
with complications).
F) Other 
recipient illnesses
Someone with kidney failure may have conditions 
other than kidney failure, which are not life-
threatening but do affect their quality of life. 
Respondents might or might not wish to allocate 
kidneys according to such conditions. Examples 
would be (see next column)
1) Healthy except for kidney 
disease.
2) Kidney disease with a 
condition that sometimes 
affects their activities, such as 
mild asthma.
3) Kidney disease with a 
condition that affects their 
activities on a daily basis, 
such as severe arthritis.
Table 1. Details of attributes and levels used in the UK renal transplant discrete choice experiments (DCE) 
preference study.NEPHROLOGY  •  July 2013    EMJ EUROPEAN MEDICAL JOURNAL 55
Dialysis DCE/CA Analyses 
The aforementioned Canadian DCE,8 included the 
attribute ‘how should decisions to stop dialysis be 
made?’ Findings revealed a preference for joint, over 
personal, decision-making for healthcare providers, 
patients, and caregivers. 
A USA analysis10 of 126 patients looked at switches 
from conventional dialysis (three times a week) to 
daily haemodialysis (six treatments of 2-3 hours 
weekly) to improve dialysis outcomes. This study 
included four attributes: life expectancy (levels of 6, 
8 or 10 years), quality of life on a 1 to 10 scale (levels 
of 5, 7 and 9), annual number of hospitalisations 
(levels of 3, 2, and 1), and transport time (levels of 
transportation time which were 3, 2, or 1 times the 
reference case [i.e. travel time for conventional 
haemodialysis]). People were more willing to switch 
to daily dialysis when the regimen offered increased 
life expectancy and better quality of life, and when 
there were larger decreases in hospitalisations and 
transport time.
Another DCE9 about nephrology facilities in Greenland 
(Denmark), estimated willingness-to-pay (WTP) for 
dialysis amongst 206 members of the general public. 
Its three attributes included numbers of specialists 
(levels of many specialists, one specialist, or monthly 
visiting specialist), accommodation for patients 
(levels of patient hotel for Greenlandic people, 
patient hotel in Nuuk, or own apartment in Nuuk), 
and increased annual tax per person (levels of 0 
DKK, 50 DKK, and 700 DKK). Findings suggested 
that alternatives involving treatment in Greenland 
were chosen in around two-thirds of cases, implying 
a tendency to favour treatment in Greenland 
even when it involves increased tax. Also WTP for 
patient hotel accommodation was higher than 
apartment accommodation, or having a permanent 
specialist. The authors concluded that Greenlanders’ 
perception of self-dependence and their attitude 
to  health  services  in  Denmark  strongly  impacted                                                            
upon findings. 
An Australian DCE study11,12 involved well-conducted 
qualitative analysis to inform the attribute and levels 
selected.13-15 One of the two DCE papers published by 
these authors surveyed 105 patients with stage 3-5 
renal disease, evaluating whether patients preferred 
dialysis or conservative treatment. Attributes 
included differences in: life expectancy, weekly 
hospital visits, ability to travel, hours attached to 
a dialysis machine, treatment timing, availability 
of subsidised transport, and flexibility of dialysis 
schedules. Findings suggested patients were more 
likely to choose dialysis than conservative care if 
dialysis increased average life expectancy, if they 
Figure 1.  Details of the instruction appearing over questions, followed by the first discrete choice 
experiments (DCE) question used in the UK renal transplant DCE preference.
NOW PLEASE READ DESCRIPTIONS OF OPTION A AND B AND INDICATE WHO YOU THINK 
SHOULD BE PRIORITISED FOR A KIDNEY TRANSPLANT – PATIENT A OR PATIENT B?:
Patient A Patient B
Amount of time a person has waited for 
a transplant
1 month 2 years
Tissue type match – and likelihood of 
transplant success
90% average 1 year 
chance of transplant 
success
86% average 1 year 
chance of transplant 
success
How many dependents (children or 
adults) recipients have 4 dependents No dependents
Recipient age 20 years 45 years
Diseases affecting life expectancy
Moderate: Uncontrolled 
hypertension or obesity
Severe: Heart attack, 
or stroke, or diabetes 
with complications.
Other recipient illnesses (other than 
kidney disease) Mild asthma Severe arthritis
Which patient would you choose?           Patient A             Patient B  
(tick 1 box only)NEPHROLOGY  •  July 2013    EMJ EUROPEAN MEDICAL JOURNAL 56
Study focus and authors
Country 
and type 
of study 
(DCE/CA) 
Sample size 
Type of attributes
End-of-life care in 
chronic kidney disease 
– kidney transplant. 
Davison et al.8
Canada, 
Renal 
transplant 
and 
dialysis 
(DCE)
169 Patients, 
150 Healthcare 
professionals,
32 Caregivers
a) For whom should live kidneys for 
transplantation be provided?
b) How should live kidneys for 
transplantation be obtained?
c) Who provides comprehensive day to 
day care?
d) How much information on end of life 
issues should be provided?
e) How should decisions to stop dialysis be 
made?
Acceptability from 
donors at increased risk 
of blood-borne viral 
infection. Reese et al.7
USA, Renal 
Transplant 
(CA)
175 Patients
a) HIV infection risk 
b) Donor age
c) Transplant waiting time (years)
Renal transplant 
prioritisation by 
stakeholders. Clark et 
al.1,2
UK, Renal 
Transplant 
(DCE)
908 Patients
113 Healthcare 
professionals
48 Live donors/ 
relatives of 
deceased donors
41 carers
a) Waiting period
b) Tissue type matching
c) Dependents
d) Recipient age
e) Diseases impacting life expectancy
f) Other illnesses
Willingness to switch 
from conventional to 
daily haemodialysis. 
Halpern et al.10
USA, 
Dialysis 
(DCE)
126 Patients
a) Life expectancy
b) Quality of life 
c) Number of hospitalisations
d) Transport time
Willingness to pay for 
dialysis. Kjaer et al.9
Denmark, 
Dialysis 
(DCE)
206 People
a) Numbers of specialists
b) Accommodation for patients
c) Increase in annual tax per person
Dialysis modality 
preference of patients 
with CKD. Morton et al.11
Factors influencing 
patient choice of dialysis 
versus conservative 
care. Morton et al.12
Australia, 
Dialysis 
(DCE) 
105 Patients
73 Caregivers
a) Life expectancy
b) Weekly hospital visits 
c) Ability to travel
d) Hours attached to a dialysis machine
e)Treatment timing
f) Availability of subsidised transport
g) Flexibility of dialysis schedule
Preferences for home-
based haemodialysis 
or peritoneal dialysis 
or hospital-based 
haemodialysis. Higgins 
et al.6
UK, 
Dialysis 
(DCE)
663 Patients
a) Frequency of dialysis
b) Quality of dialysis
c) Type of care 
d) Timing of dialysis 
e) Dialysis costs to NHS 
Table 2. Salient features of discrete choice experiments/conjoint analysis renal transplant and dialysis 
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could dialyse during the day or evening not just 
the day, and if subsidised transport was available. 
Patients were less likely to choose dialysis if more 
visits to hospital were required, or with more 
restrictions on patient travel.
The other DCE published by these authors reports 
from the same study, but also reports results for 73 
caregivers. Findings suggest home-based dialysis 
(either peritoneal or haemodialysis) was chosen by 
patients in 65% of cases, whilst the in-centre dialysis 
option was chosen in 35% of cases, and conservative 
care in 10% of cases. For caregivers, figures were 
72%, 25%, or 3% respectively. Patients and caregivers 
preferred longer to shorter hours of dialysis, but 
were less likely to choose nocturnal than daytime 
dialysis. Patients would trade-off 23 months of life 
expectancy with home-based dialysis to decrease 
their travel restrictions, amongst caregivers the 
figure was 17 months.
The UK dialysis DCE6 involved comparison of 
preferences for different modes of dialysis amongst 
636 patients, comparing home-based peritoneal 
dialysis, unit-based haemodialysis, and home-based 
haemodialysis. Attribute levels, which included 
frequency of dialysis, quality of dialysis, level of care 
(self care, shared care, or professional care), timing 
of dialysis, and the costs to the NHS of dialysis varied 
across the labelled choices in line with feasible 
ranges for the modes of dialysis. Findings suggested 
that compared to dialysis unit haemodialysis, 
home peritoneal dialysis was valued positively, 
whilst home haemodialysis was valued negatively. 
Increasing dialysis frequency was negatively valued, 
but positively valued if it raised dialysis quality. More 
flexible dialysis timing was positively valued, whilst 
cost of dialysis provision to the NHS was statistically 
significant, but not highly valued.
DISCUSSION
DCE/CA may be more rigorous than other 
methodologies. For example, if the alternative is a 
series of questions about how a respondent ranks 
options independently on a scale,16-18 or involves 
preference ranking exercises19 or choice scenarios.20,21 
This is because DCE/CA provide a robust method 
for measuring the preferences of stakeholders in 
dialysis and transplantation compatible with the 
characteristics theory of demand. 
Other approaches to evaluation in nephrology 
involve assessment of health-related quality of life.22-
28 This may involve the use of validated quality of 
life instruments.29 However, such approaches have 
the disadvantage that they do not establish what 
patients prefer, which CA/DCE analysis does. Some 
analyses have tried to establish revealed preferences 
i.e. by looking at the characteristics of patients who 
do or do not switch dialysis therapy.30,31 However, 
if such switches are driven by preferences, it is 
unclear whether they are renal physicians or patient 
preferences. In contrast, because DCEs can be used 
to compare the preferences of different stakeholder 
groups, differences in preferences between groups 
can be ascertained.1,2,8,11
Some other studies have tried to establish how 
respondents stated preferences for dialysis are 
related to patient characteristics,17,32 and one study 
has looked at how nephrologist preferences for 
dialysis vary according to their characteristics.33 
Moreover, there are preference studies that do not 
involve DCE/CA methods, e.g. relating to establishing 
priority criteria for renal transplants.21,34,35 However, a 
limitation of these types of studies is that they may 
fail to take into account the fact that preferences 
vary according to the characteristics of the different 
modes of dialysis, or may fail to robustly establish 
trade-offs between conflicting allocation criteria 
for kidney transplants because preferences are not 
related to attributes. In contrast, CA/DCE preference 
studies can establish how preferences are related to 
attributes of dialysis provision6,9,10 or different priority 
criteria for transplants.1,2,8
Also, whilst there can be a useful role for using 
qualitative analysis to establish preferences,13,14 
there may be a very strong case for using such 
analysis to design DCEs11 rather than to replace DCE 
analysis. When the authors of this paper have been 
involved in producing DCE questionnaires, both in 
relation to our transplant DCE,1,2 and also our dialysis 
DCE,6 we have been very keen to conduct rigorous 
qualitative analysis to determine the attributes and 
levels for the questionnaires before conducting the 
final DCE analysis. This adds enormous value over 
more traditional questionnaire approaches which 
may exclude this design step, and instead chooses 
attributes based upon researcher’s preference.   
Moreover, if analyses are DCEs not CAs, the analysis 
will also be strongly grounded in RUT or RRM, as 
well as the characteristics theory of demand, so 
measured preferences should equate to respondents’ 
actual preferences. One exception to this may be if 
an attempt is made to establish WTP.36 A particular 
problem is that if WTP is calculated when healthcare 
provision is free at the point of use, choices posed NEPHROLOGY  •  July 2013    EMJ EUROPEAN MEDICAL JOURNAL 58
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patient preferences for kidney allocation 
according to ethnicity and gender. 
Diversity in Health and Care. 2009;6:181-
91.
3. Lancaster KJ, New Approach to 
Consumer Theory. Journal of Political 
Economy 1966;74(2):132-57.
4. de Bekker-Grob EW, Ryan M, Gerard 
K. Discrete choice experiments in health 
economics: a review of the literature. 
Health Econ. 2012;21(2):145-72.
5. Ryan M, Gerard K. Using discrete 
choice experiments to value health care 
programmes: current practice and future 
research reflections. Appl Health Econ 
Health Policy. 2003;2(1):55-64.
6. Higgins R, et al. Establishing 
preferences for different modes of 
dialysis, and different characteristics of 
dialysis provision, using labelled choice 
Discrete Choice Experiment (DCE) 
questionnaires. British Transplantation 
Society (BTS) Conference. 13-15th March, 
2013, Bournemouth, United Kingdom.
7. Reese PP, et al. Determinants of the 
decision to accept a kidney from a 
donor at increased risk for blood-borne 
viral infection. Clin J Am Soc Nephrol. 
2010;5(5):917-23.
8. Davison SN, Kromm SK, Currie 
GR. Patient and health professional 
preferences for organ allocation and 
procurement, end-of-life care and 
organization of care for patients with 
chronic kidney disease using a discrete 
choice experiment. Nephrol Dial 
Transplant. 2010;25(7):2334-41.
9. Kjaer T, et al. Public preferences for 
establishing nephrology facilities in 
Greenland: estimating willingness-to-pay 
using a discrete choice experiment. Eur J 
Health Econ. Sep 14 2012.
10. Halpern SD, Berns JS, Israni AK. 
Willingness of patients to switch from 
conventional to daily hemodialysis: 
looking before we leap. Am J Med. 
2004;116(9):606-12.
11. Morton RL, et al. Dialysis modality 
preference of patients with CKD and 
family caregivers: a discrete-choice study. 
Am J Kidney Dis. 2012;60(1):102-11.
12. Morton RL, et al. Factors influencing 
patient choice of dialysis versus 
conservative care to treat end-stage 
kidney disease. CMAJ. 2012;184(5):E277-
83.
13. Morton RL, et al. The views of patients 
and carers in treatment decision making 
for chronic kidney disease: systematic 
review and thematic synthesis of 
qualitative studies. BMJ. 2010;340:c112.
14. Morton RL, et al. Patient views about 
treatment of stage 5 CKD: a qualitative 
analysis of semistructured interviews. Am 
J Kidney Dis. 2010;55(3):431-40.
15. Morton RL, et al. Characteristics of 
dialysis important to patients and family 
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may lack realism. So valuations for the monetary 
attribute may be subject to hypothetical bias, biasing 
estimates of WTP. This is why, when we conducted 
our renal transplant DCE1,2 we did not incorporate a 
monetary attribute. Moreover, for our dialysis DCE 
we did not present results in terms of WTP, instead 
valuing changes in other attributes versus increased 
dialysis frequency.6 One analysis reviewed here9 
which calculated WTP may be biased because of a 
range of problems associated with calculating WTP 
using DCEs.36  These include whether estimated 
WTP obtained via DCEs may be sensitive to factors 
including: the range specified for the monetary 
attribute, or the presence or absence of payment per 
se;37 or the presence of a positive cost, rather than the 
level of cost indicated by the monetary attribute;38 
or the placement of the monetary attribute in the 
list of attributes.39 Other evidence suggests that 
the  way  attributes  are  ‘framed’  may  impact  upon         
estimated WTP.40
CONCLUSIONS 
CAs and DCEs have the disadvantage of being more 
expensive to design, deliver and analyse than simple 
questionnaires, but extra expense may be justified 
if results are more meaningful/robust. Moreover, in 
renal transplantation, DCE results endorse factors 
such as waiting time and tissue type match as 
criteria for organ allocation, and raise important 
questions about whether recipient co-morbidity 
and recipient social responsibilities should be 
included in organ allocation systems,1,2 and about 
ethnic minority preferences. For dialysis, DCEs have 
yielded important information about when dialysis 
is indicated, and about preferences for different 
modes of dialysis. 
It is difficult to provide an overview of all the potential 
additional applications of DCEs in nephrology, as 
DCEs could be used to address a wide range of 
additional nephrology research questions. However, 
if more studies are undertaken, in the interests 
of methodological rigour, they should be DCE 
analyses (not CA analyses which are incompatible 
with RUT/RRM). We would also point out that it is 
important to use rigorous qualitative analysis in the 
first instance in a pilot analysis, in order to establish 
what the attributes and levels specified in the DCE 
questionnaires are, before a DCE is conducted. 
One possible future application of DCEs might 
be to establish healthcare professionals/patients’ 
preferences relating to different characteristics for 
patient education in relation to dialysis provision. 
Also, there are other areas of self-management and 
therapy choices in nephrology, especially over non-
dialysis care of the frail elderly, where being able 
to ask patients, professionals, and carers DCE-type 
questions would be useful.
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